A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age
scientific article
Author/s
author: Sodiomon B Sirima, Jerald Sadoff, Edith C Bougouma, Amidou Diarra, Alfred B Tiono, Alphonse Ouédraogo, Issiaka Soulama, Amadou T. Konaté, Jean Baptiste Yaro, Souleymane Sanon, Youssouf Kaboré, Adama Gansané
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.